Bank of New York Mellon’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $584K | Sell |
93,281
-13,770
| -13% | -$86.2K | ﹤0.01% | 3406 |
|
|
2025
Q1 | $627K | Buy |
107,051
+781
| +0.7% | +$4.58K | ﹤0.01% | 3321 |
|
|
2024
Q4 | $874K | Buy |
106,270
+344
| +0.3% | +$2.83K | ﹤0.01% | 3214 |
|
|
2024
Q3 | $944K | Sell |
105,926
-37,101
| -26% | -$331K | ﹤0.01% | 3164 |
|
|
2024
Q2 | $1.08M | Buy |
143,027
+48,549
| +51% | +$367K | ﹤0.01% | 3149 |
|
|
2024
Q1 | $742K | Buy |
94,478
+4,193
| +5% | +$32.9K | ﹤0.01% | 3304 |
|
|
2023
Q4 | $800K | Buy |
90,285
+6,442
| +8% | +$57.1K | ﹤0.01% | 3306 |
|
|
2023
Q3 | $752K | Buy |
83,843
+1,120
| +1% | +$10K | ﹤0.01% | 3336 |
|
|
2023
Q2 | $1.02M | Buy |
82,723
+18,064
| +28% | +$223K | ﹤0.01% | 3181 |
|
|
2023
Q1 | $600K | Buy |
64,659
+14,563
| +29% | +$135K | ﹤0.01% | 3391 |
|
|
2022
Q4 | $526K | Sell |
50,096
-240
| -0.5% | -$2.52K | ﹤0.01% | 3517 |
|
|
2022
Q3 | $912K | Buy |
50,336
+10,240
| +26% | +$186K | ﹤0.01% | 3251 |
|
|
2022
Q2 | $569K | Buy |
40,096
+25,600
| +177% | +$363K | ﹤0.01% | 3512 |
|
|
2022
Q1 | $319K | Buy |
+14,496
| New | +$319K | ﹤0.01% | 3980 |
|